Usman Sagheer

Usman Sagheer

Auto-generated profile, based on publicly available information

Usman Sagheer

From the Department of Medicine, Division of Cardiology (M.U., U.S., M. Shotwell, M. Shetty, D.K.K.) and Department of Radiology (W.F., J.J.), University of Louisville School of Medicine, Rudd Heart & Lung Center, 201 Abraham Flexner Way, Ste 600, Louisville, KY 40202

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2023 in JACC: Advances
Verified
Journal Article
Open access
USUsman Sagheer
Usman Sagheer
SASadeer Al-Kindi
Sadeer Al-Kindi
SAShady Abohashem
Shady Abohashem
CPColin T. Phillips
Colin T. Phillips
JRJamal S. Rana
Jamal S. Rana
Dinesh K. KalraDinesh K. Kalra
Dinesh K. Kalra
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide. Over the past 50 years, there has been a substantial decline in the incidence of CVD and related mortality in high-income countries, largely due to the mitigation of modifiable risk factors such as smoking, hypertension, and diabetes. However, a significant burden of CVD remains in low- to middle-income countries, despite their lower prevalence of traditional risk factors; other environmental factors, particularly pollution, play a significant role in this attributable risk. Mounting evidence underscores a strong association between pollution and adverse health effects, including CVD. This article is part 1 of a 2-part state-of-the-art review and discusses air pollution and its adverse effects on CVD, highlighting pathophysiological mechanisms and methods to reduce air pollution and exposure to these pollutants.

4 January 2024 in JACC: Advances
Verified
Journal Article
Open access
USUsman Sagheer
Usman Sagheer
SASadeer Al-Kindi
Sadeer Al-Kindi
SAShady Abohashem
Shady Abohashem
CPColin T. Phillips
Colin T. Phillips
JRJamal S. Rana
Jamal S. Rana
Dinesh K. KalraDinesh K. Kalra
Dinesh K. Kalra
With a growing body of evidence that now links environmental pollution to adverse cardiovascular disease (CVD) outcomes, pollution has emerged as an important risk factor for CVD. There is thus an urgent need to better understand the role of pollution in CVD, key pathophysiological mechanisms, and to raise awareness among health care providers, the scientific community, the general population, and regulatory authorities about the CV impact of pollution and strategies to reduce it. This article is part 2 of a 2-part state-of-the-art review on the topic of pollution and CVD—herein we discuss major environmental pollutants and their effects on CVD, highlighting pathophysiological mechanisms, and strategies to reduce CVD risk.

15 July 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
DPDarshan Patel
Darshan Patel
MKMarlys L. Koschinsky
Marlys L. Koschinsky
AAAnandita Agarwala
Anandita Agarwala
PNPradeep Natarajan
Pradeep Natarajan
HBHarpreet S. Bhatia
Harpreet S. Bhatia
Dinesh K. KalraDinesh K. Kalra
Dinesh K. Kalra
South Asian individuals (SA), representing approximately one quarter of the global population, experience a disproportionately high burden of cardiovascular disease. Some of this increased susceptibility is accounted for by traditional risk factors such as diabetes, hypertension, carbohydrate‐rich diets, and rising rates of obesity and metabolic syndrome. However, other previously underappreciated risk factors may also play a crucial role. These include environmental pollution, genetic factors, and Lp(a) (lipoprotein(a)). Various epidemiological and genetic studies support the role of Lp(a) as a causal and independent risk factor for atherosclerotic cardiovascular disease. SA have a higher prevalence of elevated Lp(a) levels (25% have levels >50 mg/dL) compared with Western populations, and this may be one factor that accounts for the earlier age of onset of coronary artery disease, its more aggressive course, and higher morbidity and mortality in this group. SA experience myocardial infarction nearly 10 years earlier than individuals of European descent and have higher rates of premature and multivessel coronary artery disease. Additionally, socioeconomic shifts, cultural practices, and disparities in health care access may further exacerbate these risks, creating a complex interplay of factors that heighten cardiovascular vulnerability in SA. In this article, we review the data on the role of Lp(a) in mediating atherosclerotic cardiovascular disease, its epidemiology in SA, current screening guidelines, and drugs in the pipeline that will potentially be able to reduce high Lp(a) levels and associated cardiovascular risk. Ultimately, outcome trials with such drugs will be needed in this large population to examine their efficacy and safety.

21 July 2020 in Cureus
Verified
Journal Article
Open access
PDF file
MYMuhammad N. Yousaf
Muhammad N. Yousaf
HEhamid ehsan
hamid ehsan
SESajid Ehsan
Sajid Ehsan
USUsman Sagheer
Usman Sagheer
FCFizah Chaudhary
Fizah Chaudhary
Glycogenic hepatopathy (GH) is a rare complication of long-standing uncontrolled type I diabetes mellitus (TIDM) resulting in liver dysfunction and hepatomegaly due to intrahepatic deposition of glycogen. Herein we present a 19-year-old male with a history of TIDM and multiple prior hospitalizations with diabetic ketoacidosis (DKA) who presented with nausea, vomiting, right upper quadrant pain, and massive hepatomegaly. Laboratory workup was consistent with DKA and revealed a greater than 10-fold increase in liver enzymes. Despite the resolution of DKA, his liver function was worsening, and further workup was indicated. Ultimately, he underwent a liver biopsy that showed swollen hepatocytes overloaded with intracytoplasmic glycogen consistent with glycogenic hepatopathy. It is an underestimated entity and physicians should have a high index of suspicion for GH in individuals presenting with liver dysfunction, hepatomegaly, and poor glycemic control in TIDM. Strict glycemic control may result in complete resolution of disease.

26 August 2023 in QJM: An International Journal of Medicine
Verified
Journal Article
Open access
PDF file
USUsman Sagheer
Usman Sagheer
MSMatthew K Shotwell
Matthew K Shotwell
MUMuhammad Umer
Muhammad Umer
WFWilfred Furtado
Wilfred Furtado
JJJonathan Joshi
Jonathan Joshi
Dinesh K. KalraDinesh K. Kalra
Dinesh K. Kalra
Usman Sagheer, MD, Matthew K Shotwell, MD, Muhammad Umer, MD, Wilfred Furtado, MD, Jonathan Joshi, MD, Dinesh K Kalra, MD; COVID-19-related Subclinical Myocardi

6 May 2024 in JACC: Case Reports
Verified
Journal Article
Open access
USUsman Sagheer
Usman Sagheer
SBSagar Bhandari
Sagar Bhandari
MUMuhammad Umer
Muhammad Umer
MPMatthew Peters
Matthew Peters
MSMatthew Shotwell
Matthew Shotwell
Dinesh K. KalraDinesh K. Kalra
Dinesh K. Kalra
Esophago-pericardial fistula is a rare, life-threatening condition, usually arising as a complication of benign esophageal disorders or iatrogenic causes. Prompt diagnosis via multimodality imaging is crucial, with computed tomography being the most sensitive. Management varies based on severity, with a growing trend toward early endoscopic interventions, which result in improved outcomes.